Dexcom entered the consumer health market with the launch of Stelo, an OTC glucose sensor for non-insulin users. This strategic shift into a new channel requires building new capabilities in direct-to-consumer marketing, e-commerce, and retail distribution.
Filing excerpt
In August 2024, we launched Stelo, our biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kchannelShiftGet every 10-K signal for Dexcom and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Dexcom this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/382b59ec-a7f7-4ef7-a42f-c492c382c5b9 returns this record as JSON. POST /v1/companies/enrich returns every signal for dexcom.com.
{
"signal_id": "382b59ec-a7f7-4ef7-a42f-c492c382c5b9",
"signal_type": "sec-10k",
"signal_subtype": "channelShift",
"detected_at": "2026-02-17T06:33:02.596+00:00",
"company": {
"name": "Dexcom",
"domain": "dexcom.com"
},
"data": {
"detail": "Dexcom entered the consumer health market with the launch of Stelo, an OTC glucose sensor for non-insulin users. This strategic shift into a new channel requires building new capabilities in direct-to-consumer marketing, e-commerce, and retail distribution.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Launched Stelo, its first over-the-counter (OTC) biosensor, in August 2024",
"excerpts": "In August 2024, we launched Stelo, our biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/dxcm-20251231.htm",
"filing_date": "2026-02-12",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "New channel tools needed",
"signal_category": "market",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/382b59ec-a7f7-4ef7-a42f-c492c382c5b9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"dexcom.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.